MARKET

JNJ

JNJ

Johnson&Johnson
NYSE

Real-time Quotes | Nasdaq Last Sale

164.08
+0.53
+0.32%
Opening 09:56 01/25 EST
OPEN
165.27
PREV CLOSE
163.55
HIGH
165.46
LOW
163.66
VOLUME
1.44M
TURNOVER
--
52 WEEK HIGH
165.46
52 WEEK LOW
109.16
MARKET CAP
431.95B
P/E (TTM)
26.25
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
This Earnings Week Will Be a Busy One
Jan 25, 2021 (IAM Newswire via COMTEX) -- Apply (NASDAQ: AAPL), Facebook (NASDAQ: FB), Microsoft (NASDAQ: MSFT) and Tesla (NASDAQ: TSLA) are ready to report...
IAM Newswire · 1h ago
DJ Merck Scraps Covid-19 Vaccine Programs -- Barrons.com
Dow Jones · 1h ago
Tata In Partnership Talks With Moderna To Launch COVID-19 Vaccine In India: Report
Indian conglomerate Tata Sons are in discussion with Moderna Inc (NASDAQ: MRNA) for a partnership with its healthcare unit Tata Medical & Diagnostics, the 
Benzinga · 3h ago
Merck ends COVID vaccine program, cites inferior immune responses
reuters.com · 3h ago
Johnson & Johnson, Boeing, Facebook, Apple and Tesla are part of Zacks Earnings Preview
Zacks.com · 3h ago
UPDATE 1-Pfizer requests S.Korea approval COVID-19 vaccines ahead of February rollout
reuters.com · 5h ago
COVID-19 Vaccine Update New Strains and Supply Issues Remain a Concern
FX Empire · 7h ago
Tech’s ‘last hurrah?’ If hedge funds are any indication, it could be a big week for Apple, Amazon and other prominent megacaps
According to Goldman Sachs Group's prime brokerage, hedge funds increased their net exposure to megacaps in the technology sector at one of the fastest paces...
marketwatch.com · 19h ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of JNJ. Analyze the recent business situations of Johnson&Johnson through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average JNJ stock price target is 168.18 with a high estimate of 181.00 and a low estimate of 139.00.
EPS
Institutional Holdings
Institutions: 3.63K
Institutional Holdings: 1.91B
% Owned: 72.52%
Shares Outstanding: 2.63B
TypeInstitutionsShares
Increased
1.35K
35.94M
New
172
-607.90K
Decreased
1.16K
47.07M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.03%
Pharmaceuticals & Medical Research
+0.39%
Key Executives
Chairman/Chief Executive Officer/Director
Alex Gorsky
Vice Chairman - Management/Chief Scientific Officer
Paulus Stoffels
Vice Chairman - Management
Joaquin Duato
Chief Financial Officer/Executive Vice President
Joseph Wolk
Chief Human Resource Officer/Executive Vice President
Peter Fasolo
Executive Vice President/General Counsel
Michael Ullmann
Executive Vice President
Ashley McEvoy
Executive Vice President
Thibaut Mongon
Executive Vice President
Michael Sneed
Executive Vice President
Jennifer Taubert
Executive Vice President
Kathryn Wengel
Lead Director/Independent Director
Anne Mulcahy
Independent Director
Mary Beckerle
Independent Director
D. Scott Davis
Independent Director
Ian Davis
Independent Director
Jennifer Doudna
Independent Director
Marillyn Hewson
Independent Director
Hubert Joly
Independent Director
Mark McClellan
Independent Director
Charles Prince
Independent Director
A. Eugene Washington
Independent Director
Mark Weinberger
Independent Director
Ronald Williams
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
01/04/2021
Dividend USD 1.01
02/22/2021
10/22/2020
Dividend USD 1.01
11/23/2020
07/20/2020
Dividend USD 1.01
08/24/2020
04/14/2020
Dividend USD 1.01
05/22/2020
01/02/2020
Dividend USD 0.95
02/24/2020
10/17/2019
Dividend USD 0.95
11/25/2019
07/15/2019
Dividend USD 0.95
08/26/2019
04/25/2019
Dividend USD 0.95
05/24/2019
01/02/2019
Dividend USD 0.9
02/25/2019
10/18/2018
Dividend USD 0.9
11/26/2018
07/16/2018
Dividend USD 0.9
08/27/2018
04/26/2018
Dividend USD 0.9
05/25/2018
01/02/2018
Dividend USD 0.84
02/26/2018
10/19/2017
Dividend USD 0.84
11/27/2017
07/17/2017
Dividend USD 0.84
08/25/2017
04/27/2017
Dividend USD 0.84
05/25/2017
01/03/2017
Dividend USD 0.8
02/24/2017
10/21/2016
Dividend USD 0.8
11/18/2016
07/18/2016
Dividend USD 0.8
08/19/2016
04/28/2016
Dividend USD 0.8
05/20/2016
01/04/2016
Dividend USD 0.75
02/19/2016
10/22/2015
Dividend USD 0.75
11/20/2015
07/20/2015
Dividend USD 0.75
08/21/2015
04/23/2015
Dividend USD 0.75
05/21/2015
01/05/2015
Dividend USD 0.7
02/20/2015
10/16/2014
Dividend USD 0.7
11/21/2014
07/21/2014
Dividend USD 0.7
08/22/2014
04/24/2014
Dividend USD 0.7
05/22/2014
01/02/2014
Dividend USD 0.66
02/21/2014
10/17/2013
Dividend USD 0.66
11/22/2013
07/15/2013
Dividend USD 0.66
08/23/2013
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About JNJ
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.
More

Webull offers kinds of Johnson & Johnson stock information, including NYSE:JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.